Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of aripiprazole once-monthly in schizophrenia
2012-003239-47Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Lundbeck. Started Jul 2013; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2012-003239-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003239-47.